Your browser doesn't support javascript.
loading
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.
Wachter, Rolf; Senni, Michele; Belohlavek, Jan; Straburzynska-Migaj, Ewa; Witte, Klaus K; Kobalava, Zhanna; Fonseca, Candida; Goncalvesova, Eva; Cavusoglu, Yuksel; Fernandez, Alberto; Chaaban, Said; Bøhmer, Ellen; Pouleur, Anne-Catherine; Mueller, Christian; Tribouilloy, Christophe; Lonn, Eva; A L Buraiki, Jehad; Gniot, Jacek; Mozheiko, Maria; Lelonek, Malgorzata; Noè, Adele; Schwende, Heike; Bao, Weibin; Butylin, Dmytro; Pascual-Figal, Domingo.
Affiliation
  • Wachter R; Clinic and Policlinic for Cardiology, University Hospital Leipzig, and Clinic for Cardiology, University Medicine Göttingen and German Cardiovascular Research Center, Partner Site, Göttingen, Germany.
  • Senni M; Cardiology Division, Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Belohlavek J; General Teaching Hospital, Charles University in Prague, Prague, Czech Republic.
  • Straburzynska-Migaj E; First Department of Cardiology, University of Medical Sciences, Poznan, Poland.
  • Witte KK; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
  • Kobalava Z; Peoples' Friendship University of Russia (RUDN University), Moscow, Russia.
  • Fonseca C; Heart Failure Unit, Internal Medicine Department, Hospital de São Francisco Xavier, CHLO, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Goncalvesova E; Odd. Srdcovehozlyhavania a Transplantacie, Bratislava, Slovakia.
  • Cavusoglu Y; Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey.
  • Fernandez A; Sanatorio Modelo Quilmes, Buenos Aires, Argentina.
  • Chaaban S; Hammoud Hospital University Medical Center, Saida, Lebanon.
  • Bøhmer E; Innlandet Hospital Trust, Lillehammer, Norway.
  • Pouleur AC; Cardiology Division, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Mueller C; University Hospital Basel, University of Basel, Basel, Switzerland.
  • Tribouilloy C; Department of Cardiology, Amiens University Hospital, Amiens, France.
  • Lonn E; McMaster University and Hamilton Health Sciences, Hamilton, Canada.
  • A L Buraiki J; King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
  • Gniot J; SP ZOZ Szpital Specjalistyczny, Pulawy, Poland.
  • Mozheiko M; Yaroslavl Regional Hospital of Veterans of Wars, Yaroslavl, Russia.
  • Lelonek M; Department of Noninvasive Cardiology, Medical University of Lodz, Lodz, Poland.
  • Noè A; Novartis Pharma AG, Basel, Switzerland.
  • Schwende H; Novartis Pharma AG, Basel, Switzerland.
  • Bao W; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • Butylin D; Novartis Pharma AG, Basel, Switzerland.
  • Pascual-Figal D; Cardiology Department, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain.
Eur J Heart Fail ; 21(8): 998-1007, 2019 08.
Article in En | MEDLINE | ID: mdl-31134724

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Discharge / Tetrazoles / Aminobutyrates / Heart Failure / Hemodynamics Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2019 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Discharge / Tetrazoles / Aminobutyrates / Heart Failure / Hemodynamics Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Eur J Heart Fail Journal subject: CARDIOLOGIA Year: 2019 Type: Article Affiliation country: Germany